Autoimmunity, spontaneous tumourigenesis, and IL‐15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1-Reference-Cited by-同舟云学术

Autoimmunity, spontaneous tumourigenesis, and IL‐15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1

Published:2007-02-22 Issue:5 Volume:211 Page:591-601
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Ivanova AV¹,Ivanov SV¹,Pascal V²,Lumsden JM³,Ward JM⁴,Morris N⁵,Tessarolo L⁶,Anderson SK²,Lerman MI⁷

Affiliation:

1. Laboratory of Immunobiology, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA

2. Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA

3. Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA

4. Comparative Medicine Branch, NIAID, & SoBran, Inc., Rockville, MD 20892 USA

5. Laboratory Animal Sciences Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA

6. Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA

7. Basic Research Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.2146

Reference51 articles.

1. The 630‐kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium;Lerman MI;Cancer Res,2000

2. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells

3. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo

4. The Hallmarks of Cancer

5. The Three Es of Cancer Immunoediting

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory Impairment;International Journal of Molecular Sciences;2024-07-05

2. Pharmacological Modulation of Energy and Metabolic Pathways Protects Hearing in the Fus1/Tusc2 Knockout Model of Mitochondrial Dysfunction and Oxidative Stress;Antioxidants;2023-06-06

3. Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy;Cancers;2023-04-25

4. NEDD4 degrades TUSC2 to promote glioblastoma progression;Cancer Letters;2022-04

5. Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications;Cancer Gene Therapy;2022-02-18